Page last updated: 2024-10-29
iodixanol and Cicatrization
iodixanol has been researched along with Cicatrization in 1 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
Cicatrization: The formation of fibrous tissue in the place of normal tissue during the process of WOUND HEALING. It includes scar tissue formation occurring in healing internal organs as well as in the skin after surface injuries.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Lardo, AC | 1 |
| Cordeiro, MA | 1 |
| Silva, C | 1 |
| Amado, LC | 1 |
| George, RT | 1 |
| Saliaris, AP | 1 |
| Schuleri, KH | 1 |
| Fernandes, VR | 1 |
| Zviman, M | 1 |
| Nazarian, S | 1 |
| Halperin, HR | 1 |
| Wu, KC | 1 |
| Hare, JM | 1 |
| Lima, JA | 1 |
Clinical Trials (2)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Microvascular Obstruction by Contrast-enhanced MRI Following Percutaneous Coronary Interventions[NCT00692991] | | 144 participants (Actual) | Observational | 1999-10-31 | Completed |
| Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging[NCT00857792] | | 120 participants (Actual) | Interventional | 2009-03-31 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Ability to Detect Stress-induced Myocardial Perfusion Abnormalities by Analysis of MDCT Images Confirmed by Coronary Angiography and/or SPECT.
(NCT00857792)
Timeframe: 3 months
| Intervention | % accurately detected perfusion defects (Number) |
|---|
| Open Label | 78 |
Other Studies
1 other study available for iodixanol and Cicatrization
| Article | Year |
|---|
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.Circulation, 2006, Jan-24, Volume: 113, Issue:3
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.Circulation, 2006, Jan-24, Volume: 113, Issue:3
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.Circulation, 2006, Jan-24, Volume: 113, Issue:3
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.Circulation, 2006, Jan-24, Volume: 113, Issue:3
Topics: Acute Disease; Animals; Cell Death; Chronic Disease; Cicatrix; Contrast Media; Coronary Angiography; | 2006 |